Rhenman & Partners Asset Management Ab Sangamo Therapeutics, Inc Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.66 - $3.67 $839,699 - $1.86 Million	-505,843 Reduced 61.69%	314,157 $552,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $512,399 - $766,800	120,000 Added 17.14%	820,000 $3.6 Million
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.21 $201,487 - $381,474	-61,429 Reduced 8.07%	700,000 $2.9 Million
Q1 2022 May 13, 2022	SELL	$5.23 - $7.82 $18,676 - $27,925	-3,571 Reduced 0.47%	761,429 $4.42 Million
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $618,941 - $969,940	-56,888 Reduced 6.92%	765,000 $9.59 Million
Q4 2020 Jan 19, 2021	BUY	$9.23 - $18.18 $1.36 Million - $2.67 Million	146,888 Added 21.76%	821,888 $12.8 Million
Q2 2020 Jul 16, 2020	SELL	$6.21 - $11.83 $155,250 - $295,750	-25,000 Reduced 3.57%	675,000 $6.05 Million
Q4 2019 Jan 17, 2020	SELL	$8.03 - $11.7 $279,532 - $407,288	-34,811 Reduced 4.74%	700,000 $5.86 Million
Q3 2019 Oct 16, 2019	SELL	$9.05 - $12.22 $535,271 - $722,764	-59,146 Reduced 7.45%	734,811 $6.65 Million
Q2 2019 Jul 22, 2019	SELL	$8.75 - $13.03 $437,500 - $651,500	-50,000 Reduced 5.92%	793,957 $8.55 Million
Q1 2019 Apr 11, 2019	SELL	$7.72 - $12.81 $2.01 Million - $3.33 Million	-260,000 Reduced 23.55%	843,957 $8.05 Million
Q4 2018 Feb 05, 2019	SELL	$9.51 - $16.6 $888,234 - $1.55 Million	-93,400 Reduced 7.8%	1,103,957 $12.7 Million
Q3 2018 Oct 03, 2018	BUY	$13.05 - $19.05 $1.9 Million - $2.77 Million	145,424 Added 13.82%	1,197,357 $20.3 Million
Q2 2018 Jul 20, 2018	BUY	$13.9 - $19.8 $11.1 Million - $15.8 Million	796,140 Added 311.24%	1,051,933 $14.9 Million
Q4 2017 Jan 19, 2018	BUY	$11.6 - $17.35 $2.97 Million - $4.44 Million	255,793	255,793 $4.2 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.4 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.58 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.41 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.71 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account